-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase II clinical trial (SYH2062-003) of the SYH2062 injection developed by the group to treat essential hypertension in adults has been officially launched at the first center in China.

Zhitongcaijing·07/29/2026 12:41:22
Listen to the news
Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase II clinical trial (SYH2062-003) of the SYH2062 injection developed by the group to treat essential hypertension in adults has been officially launched at the first center in China.